Project cooperationUpdated on 23 June 2026
Clinical trial sites for clinical performance Study in colorectal cancer
Clinical Director at CanSense Ltd
About
CanSense are looking to connect with hospital provider sites involved with colorectal cancer investigation and treatment, and endoscopy facilities who are able to recruit patients having investigations to detect or rule out colorectal cancer.
Stage
- Design - setting the project scope
- Completing the consortia
Type
- Capital contribution
- Technical
- Strategic Partnership
- Technological contribution
- Consortium seeks Partners
Organisation
Similar opportunities
Project cooperation
Seeking Pharma Co-Development Partner | World's First RAGE-Targeted ADC | Solid Tumour Oncology
- Technical
- Capital contribution
- Strategic Partnership
- Technological contribution
Gareth Morgan
CEO at Viamab Therapeutics L
Investment
- Series A | Scale business
Dean Harris
Clinical Director at CanSense Ltd
Service
Colorectal cancer diagnostic testing
- Testing & Analysis
- Research & Development
Dean Harris
Clinical Director at CanSense Ltd